Point72 Hong Kong Ltd - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2021$362,000
+176.3%
4,825
+328.5%
0.01%
+225.0%
Q3 2021$131,000
-86.3%
1,126
-73.9%
0.00%
-87.1%
Q2 2021$958,000
+177.7%
4,317
+39.3%
0.03%
-16.2%
Q3 2020$345,000
+65.9%
3,099
-11.6%
0.04%
+60.9%
Q2 2020$208,000
+20700.0%
3,505
+24935.7%
0.02%
Q3 2019$1,000
-96.9%
14
-97.2%
0.00%
-100.0%
Q2 2019$32,000
+1500.0%
503
+1337.1%
0.01%
+800.0%
Q1 2019$2,000
-93.3%
35
-93.8%
0.00%
-90.0%
Q3 2018$30,0005630.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders